Chemotherapy of Hodgkin's Disease: Maintenance Therapy vs No Maintenance After Remission Induction With Combination Chemotherapy

James K. Luce, Emil Frei, Edmund A. Gehan, Charles A. Coltman, Robert Talley, Raymond W. Monto

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

A therapeutic regimen (MOPP) that consisted of a combination of mechlorethamine hydrochloride, 3 to 6 mg/sq m intravenously, days 1 and 8, vincristine sulfate, 0.7 or 1.4 mg/sq m intravenously, days 1 and 8, procarbazine hydrochloride, 50 or 100 mg/sq m orally, every day for ten days, and prednisone, 40 mg/sq m orally, every day for ten days, was given every four weeks for 24 weeks to 164 patients with disseminated Hodgkin's disease. Patients in complete remission then received either no therapy or MOPP therapy every eight weeks. One hundred six patients achieved a complete remission (65%). The remission rate for stages IIIA, IIIB, and IVA ranged between 78% and 82%; for IVB it was 56%. At 95 weeks, 78% of the patients receiving maintenance therapy and only 50% of those not receiving maintenance were still in complete remission.

Original languageEnglish (US)
Pages (from-to)391-395
Number of pages5
JournalArchives of Internal Medicine
Volume131
Issue number3
DOIs
StatePublished - Mar 1973
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Chemotherapy of Hodgkin's Disease: Maintenance Therapy vs No Maintenance After Remission Induction With Combination Chemotherapy'. Together they form a unique fingerprint.

Cite this